Xiaokai Zhang

Title: Innovative Contributions of Inventor Xiaokai Zhang

Introduction

Xiaokai Zhang is a notable inventor based in Beijing, China, recognized for his significant contributions to the pharmaceutical industry. With one patent to his name, he has made strides in developing compounds that play a crucial role in treating diseases linked to abnormal protein kinases.

Latest Patents

Xiaokai Zhang holds a patent for a quinolyl-substituted carboxylic acid compound, which includes a pharmaceutically acceptable salt thereof. This invention also covers the pharmaceutical composition of the compound and its applications. The compound serves as an inhibitor for AXL and/or VEGFR2 protein kinase, which can be instrumental in treating various diseases, including tumors associated with dysfunction in these protein kinases.

Career Highlights

Xiaokai works at Beijing Konruns Pharmaceutical Co., Ltd., where he leverages his expertise to advance pharmaceutical research and development. His work not only reflects his innovative spirit but also highlights the importance of collaboration within the scientific community.

Collaborations

Throughout his career, Xiaokai has collaborated with talented individuals such as Zhiqiang Zhang and Xijuan Wang, whose contributions have likely enhanced the quality and breadth of the research undertaken at their company.

Conclusion

Inventor Xiaokai Zhang exemplifies the spirit of innovation within the pharmaceutical sector. His patent for a valuable quinolyl-substituted carboxylic acid compound illustrates his commitment to advancing medical science and improving treatment options for patients. Through his work at Beijing Konruns Pharmaceutical Co., Ltd., and collaboration with fellow researchers, he continues to make impactful contributions in the arena of drug development.